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The transcription factor Tcf1 is essential for the
development of natural killer (NK) cells. However,
its precise role has not been clarified. Our combined
analysis of Tcf1-deficient and transgenic mice indi-
cated that Tcf1 guides NK cells through three stages
of development. Tcf1 expression directed bone
marrow progenitors toward the NK cell lineage and
ensured the survival of NK-committed cells, and its
downregulation was needed for terminal maturation.
Impaired survival of NK-committed cells was due to
excessive expression of granzyme B (GzmB) and
other granzyme family members, which induced NK
cell self-destruction during maturation and following
activation with cytokines or target cells. Mechanisti-
cally, Tcf1 binding reduced the activity of a Gzmb-
associated regulatory element, and this accounted
for the reducedGzmb expression in Tcf1-expressing
NK cells. These data identify an unexpected require-
ment to limit the expression of cytotoxic effector
molecules for the normal expansion and function of
NK cells.
INTRODUCTION
Natural killer (NK) cells represent the innate counterpart of cyto-
toxic CD8+ T cells and play important roles in the clearance of not
only certain pathogens but also pathogen-infected and trans-
formed host cells. While CD8+ T cells use somatically rearranged
T cell receptors (TCRs) to detect antigens on host cells, NK cells
utilize a set of germline-encoded activation and inhibition recep-
tors to determinewhether host cells express specific self-ligands
at normal levels. Both effector cell types respond to aberrant
host cells by the production of cytokines, including interferon-g
(IFN-g), and by the directed release of cytolytic granules con-
taining perforin and multiple distinct granzymes, which trigger
a suicide program in target cells.This is an open access article under the CC BY-NWhile all lymphocytes can be derived from bone marrow (BM)
resident common lymphoid progenitors (CLPs), lymphocytes
lacking antigen receptors (i.e., innate lymphoid cells [ILCs] and
NK cells) can be derived from a shared downstream early innate
lymphoid progenitor (EILP) (Yang et al., 2015). Subsequently, NK
cells arise via the pre-NK (LinCD127+CD135CD122) and rNK
(LinCD127+CD135CD122+) stages (Carotta et al., 2011; Fath-
man et al., 2011). Even though pre-NK cells efficiently give rise to
NK cells, it is not clear whether they have lost ILC potential.
Based on the upregulation of interleukin-2/15Rb (IL-2/15Rb)
(CD122), rNK cells may be considered the earliest NK-cell-line-
age-committed progenitor. Indeed, IL-15 receptor signaling is
a critical rate-limiting step for NK cell development, expansion,
and survival (Vosshenrich et al., 2005). Further development is
characterized by the acquisition of germline-encoded NK cell re-
ceptors and an expansion phase, which yields a pool of mature
(CD122+DX5+NK1.1+) BMNKcells (mNK). An additional hallmark
of NK cell development is the acquisition of an effector cell pro-
gram in their tissue of origin. BM NK cells constitutively express
considerable levels of perforin, granzyme B (GzmB), and IFN-g
mRNAs that are, however, not efficiently translated into protein
(Fehniger et al., 2007; Stetson et al., 2003). Further NK cell matu-
ration can be followed based on the transient upregulation of
CD27 followed by the upregulation CD11b and KLRG1. During
this maturation, NK cells progressively lose homeostatic expan-
sion capacity, gain cytolytic potential (Chiossone et al., 2009),
and become prone to apoptosis (Robbins et al., 2004).
Several transcription factors impact specific stages of NK cell
development and maturation. For example, Nfil3 (E4BP4) com-
mits progenitors to the NK cell lineage (Male et al., 2014), and
Eomes, together with T-bet (Tbx21), is essential for the further
development of NK-committed progenitors (Gascoyne et al.,
2009; Gordon et al., 2012). The latter and additional transcription
factors (e.g., Id2) act at least in part by improving the responsive-
ness of immature NK cells to IL-15 (Delconte et al., 2016;
Intlekofer et al., 2005). On the other hand, multiple aspects of
the NK cell developmental program including for example the
acquisition of NK cell receptors, the establishment of the effector
program, and relevant control mechanisms, remain poorly
understood.Cell Reports 20, 613–626, July 18, 2017 ª 2017 The Author(s). 613
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
The transcription factor Tcf1 (encoded by the Tcf7 gene)
was initially found to be required for the acquisition of certain
Ly49 family NK cell receptors as well as for NK cell develop-
ment (Held et al., 1999). More recently it was shown that
pre-NK cells as well as NK-lineage-committed rNK and mNK
cells are severely reduced in the absence of Tcf1 (Yang
et al., 2015). Tcf1 binds DNA in a sequence-specific fashion
and can directly repress target genes by exerting histone de-
acetylase (HDAC) activity or via association with Groucho/TLE
co-repressors (Roose et al., 1998; Xing et al., 2016). In addi-
tion, Tcf1 can mediate the nuclear response to extracellular
Wnt proteins by binding b-catenin and/or g-catenin (Jeannet
et al., 2008; Molenaar et al., 1996). The precise role of Tcf1
in NK cell development and essential targets have not been
identified.
Here, we find that Tcf1 expression directs lymphoid progeni-
tors toward the NK cell lineage and ensures the survival of NK-
lineage-committed cells, and we also find that Tcf1 downregula-
tion is required for terminal NK cell maturation. Tcf1 ensured NK
cell survival during maturation and following activation by pre-
venting excessive granzyme expression, which induced NK
cell self-destruction. Tcf1 reduced the activity a regulatory
element in the vicinity of the Gzmb locus, and this accounted
for reduced GzmB expression. Limiting the expression of gran-
zymes thus plays an unexpected and essential role for NK cell
development.
RESULTS
Tcf1 Expression Is Upregulated Prior to NK Cell
Commitment and Ceases during Terminal Maturation
To define the role of the transcription factor Tcf1 for NK cell
development, we analyzed Tcf1 expression in a series of BM
progenitors. Using a Tcf1 reporter mouse strain (Utzschneider
et al., 2016) in which GFP expression is controlled by the Tcf7
locus (Tcf7-GFP) (Figures S1A–S1C), we confirmed lack of
Tcf7-GFP expression in CLP (defined as detailed in Experimental
Procedures) and expression in downstream LinCD127
Thy1.2 BM cells (Figures 1A and 1B) (Yang et al., 2015). Tcf7-
GFP was also homogenously expressed by pre-NK and rNK
cells (Figure 1A) and by subsets of immature NK (iNK)
cells, mNK cells, and splenic NK cells (Figures 1C and 1D).
Differentiating splenic NK cells according to their maturational
states (Chiossone et al., 2009) revealed that Tcf7-GFP ex-
pression was high in immature (CD27+CD11b) NK cells,
reduced in intermediate (CD27+CD11b+) NK cells, and essen-
tially absent in terminally mature (CD27CD11b+) NK cells
(Figure 1D), in agreement with Tcf1 protein expression (Fig-
ure 1E). The Tcf7-GFP reporter and intracellular staining
detect Tcf1 isoforms that contain an extended N terminus.
Western blots using an antibody specific for a central portion
of Tcf1 showed that splenic NK cells almost exclusively ex-
pressed the p45 Tcf1 isoform (Figure S1D), which contains
DNA-binding, repressor, and N-terminal catenin-binding do-
mains (schematically depicted in Figure S1A). Thus Tcf1 expres-
sion is induced prior to the commitment of BM progenitors to the
NK cell lineage and expression ceases upon terminal NK cell
maturation.614 Cell Reports 20, 613–626, July 18, 2017Tcf1 Expression Is Essential for NK Cell Development,
and Its Downregulation Is Required for Terminal
Maturation
We next addressed the Tcf1 dependence of NK cell develop-
mental. In the absence of Tcf1, CLPs were present normally,
but EILPs were significantly reduced (Figures 2A–2C). Further,
pre-NK, rNK, and mNK cell populations were reduced 3-
to >10-fold in the absence of Tcf1 (Figures 2B–2E), in agreement
with previous findings (Yang et al., 2015). To address whether
subdomains of Tcf1 play selective roles in NK cell development,
we analyzed Tcf7/mice expressing either a full-length (p45) or
N-terminally truncated (p33) Tcf1 transgene (Tg). The two Tg’s
share known Tcf1 functions, except that p33 cannot bind b-
and g-catenin (Figure S1A). The NK cell developmental defect
of Tcf7/ mice was rescued by the p45 Tg, but not by the p33
Tg (Figures 2B–2E). Detailed analysis of BMprogenitors revealed
that the p45 Tg expanded CLPs and restored the pre-NK, rNK,
and mNK compartments (Figures 2B–2E). Unexpectedly, p33
expression similarly expanded CLPs and restored pre-NK cells
but failed to rescue rNK and mNK cells (Figures 2B–2E). Since
homeostatic expansion of residual progenitors or NK cells
may mask developmental effects, we further analyzed competi-
tive irradiation BM chimeras. These analyses confirmed that
absence of Tcf1 reduced the pre-NK cell population and pro-
foundly impaired rNK and mNK cell development. Further the
p33 Tg restored pre-NK cells but did not rescue (or only mar-
ginally rescued) rNK and mNK cells (Figure S2A). Mixed BM chi-
meras further revealed that Tcf7/ BM contributed inefficiently
to the splenic NK cell compartment and that the p45 Tg, but not
the p33 Tg, rescued splenic NK cells (Figure S2B). Conversely,
NK cell development was normal when Tcf7+/+ BM progenitors
matured in Tcf7/ hosts (data not shown). These data indicated
that enforced Tcf1 expression restored NK cell development
whereby the catenin-binding domain in Tcf1 (present in p45)
was not essential to direct BM progenitors toward the NK cell
lineage but was needed to expand NK-committed cells.
Despite impaired NK cell development, we noted only minor
differences in the expression of activating NK cell receptors
(including NK1.1, NKp46, NKG2D, CD16, Ly49H [except for a
reduced presence of Ly49D+ NK cells], or SLAM family receptors
[SLAM, 2B4, CD84, Ly-9, Ly-108, andCRACC]) in the absence of
Tcf1 (data not shown). On the other hand, the expression of
several inhibitory receptors specific for major histocompatibility
complex (MHC) class I molecules, particularly Ly49A, was signif-
icantly altered (data not shown), as reported before (Held et al.,
1999). In addition, terminally mature BM and spleen NK cells
(CD27CD11b+ or KLRG1+) were significantly more abundant
in Tcf7/ mice (Figures 3 and S3A). A corresponding albeit
weaker effect was observed in mixed BM chimeras (Figure S3B),
indicating that the absence of Tcf7/ promoted terminal matu-
ration. Enforced Tcf1 (p45) expression resulted in efficient
CD27 upregulation but yielded few terminally mature NK cells
(CD27CD11b+ or KLRG1+) (Figures 3 and S3A). These findings,
together with the lack of Tcf1 in terminally mature wild-type NK
cells (Figures 1D and 1E), suggested that Tcf1 downregulation
was required for terminal differentiation. Thus, Tcf1 expression
promoted NK cell development, while its downregulation
allowed terminal maturation.
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Figure 1. Tcf1 Expression during NK Cell
Development and Maturation
(A) LinNK1.12B4+CD27+CD127+ bone marrow
(BM) cells were subdivided into common lymphoid
progenitors (CLPs) (CD135+CD122), pre-NK cells
(CD135CD122), and rNK cells (CD135CD122+)
and analyzed for Tcf1 expression using a Tcf7-
GFP reporter mouse strain. Histogram overlays
show Tcf7-GFP expression (open histograms) as
compared to cells from wild-type (WT) non-re-
porter mice (gray fill). Numbers indicate the per-
centage of cells in the respective gate.
(B) LinNK1.1CD127 BM cells were analyzed
for Thy1.2 versus Tcf7-GFP expression, which
identifies a population of Thy1Tcf7-GFP+ cells,
which represent early innate lymphoid progenitors
(EILPs).
(C) CD3CD122+ BM NK cells were subdivided
into iNK (DX5NK1.1+) and mNK cells (DX5+
NK1.1+) and analyzed for Tcf7-GFP expression
(open histograms) as compared cells from non-
reporter mice (WT, gray fill).
(D and E) CD3NK1.1+ spleen NK cells were
subdivided into progressively mature NK cell
populations (CD27+CD11b/ CD27+CD11b+/
CD27CD11b+) and analyzed for (D) Tcf7-GFP
expression (open histograms) as compared cells
from non-reporter mice (WT, gray fill) or (E) intra-
cellular Tcf1 staining in Tcf7+/+ (open histograms)
as compared to Tcf7/ control NK cell pop-
ulations (gray fill).
Data are representative of three to five indepen-
dent experiments. See also Figure S1.Tcf1 Deficiency Results in Excessive Granzyme
Expression
To understand the role of Tcf1 for NK cell development, we
determined the cellular basis for defective NK cell development
in the absence of Tcf1. BM mNK cells go through a stage of
active proliferation (Kim et al., 2002), which was not impaired in
the absence of Tcf1 (Figure 4A). Rather, Tcf7/ BM NK cellsCshowed evidence of enhanced cell death
(Figure 4B). Since NK cell development,
homeostasis, and expansion chiefly
depend on IL-15 signaling, we deter-
mined whether splenic NK cells from
Tcf7/ mice were responsive to IL-15
or IL-2 in vitro. Cytokine stimulation of
Tcf7/ NK cells induced normal activa-
tion, cell-cycle progression (Figure S4A),
and as many cell divisions as observed
in Tcf7+/+ NK cells (Figure 4C). Notwith-
standing, Tcf7/ NK cells failed to accu-
mulate in number (Figure 4D). This was
accounted for by an increased abun-
dance of apoptotic NK cells (Figures 4E
and S4B). When Tcf7+/+ and Tcf7/ NK
cells were mixed before stimulation,
Tcf7+/+ NK cells expanded efficiently,
while Tcf7/ NK cells did not (Figure 4F).
Thus, the reduced expansion of Tcf7/NK cells in vitro was due
to cell-autonomous apoptosis rather than reciprocal killing
(fratricide).
To elucidate the basis for deficient NK cell development and
expansion, we established the global gene expression profiles
of flow-sorted BM mNK cells from Tcf7+/+ and Tcf7/
mice. Based on three independent datasets, 20 of 28,000ell Reports 20, 613–626, July 18, 2017 615
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Figure 2. Tcf1-Dependent Stages of NK Cell Development
(A) LinNK1.1CD127BMcells from Tcf7+/+ Tcf7-GFP, Tcf7/ Tcf7-GFP and from non-reporter (WT) mice analyzed for the presence of Thy1 Tcf7-GFP+ cells.
Numbers indicate the percentage of cells in the respective gate. Bar graph depicts the mean (±SEM) number of LinNK1.1CD127Thy1 Tcf7-GFP+ (EILP) cells
per femur from six or seven mice from three independent experiments.
(B–E) Flow cytometry analysis of BM from Tcf7+/+, Tcf7/, Tcf7/ p33 Tg, and Tcf7/ p45 Tgmice. (B) LinNK1.1BMcells were analyzed for 2B4 versusCD27
expression (left). Gated 2B4+ CD27+ cells were further analyzed for CD127 versus CD117 (middle), and gated CD127+ cells were analyzed for CD135 and CD122
to identify CLP (CD135+CD122), pre-NK (CD135CD122), and rNK cells (CD135CD122+). Numbers indicate the percentage of cells in the respective gate. (D)
BM cells were analyzed for CD3 versus CD122 (left), and gated CD3CD122+ NK cells were analyzed for the presence of mNK (DX5+NK1.1+) (right). Numbers
(legend continued on next page)
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Figure 3. Absence of Tcf1 Increases and Enforced p45 Tcf1
Expression Counteracts Terminal NK Cell Maturation
Gated CD3NK1.1+ BM NK cells from Tcf7+/+, Tcf7/, Tcf7/ p33 Tg, and
Tcf7/ p45 Tg mice were analyzed for the expression of CD27 versus CD11b
(left) or KLRG1 (right). Numbers indicate the percentage of cells in the corre-
sponding gate. Data are representative of five independent experiments. See
also Figure S3.genes were differentially expressed (adjusted p value p < 0.05),
whereby 15 genes were upregulated and 5 were downregulated
in Tcf7/ compared to Tcf7+/+ BM mNK cells (Table S1). The
search for differentially expressed genes that are associated
with the Gene Ontology (GO) term ‘‘apoptosis’’ identified
members of the granzyme family. Gzmb (2.5-fold, p < 0.05)
and Granzyme C (Gzmc) (2.5-fold, p < 0.05) were upregulated
in Tcf1-deficient mNK cells (Table S1). Granzyme K (Gzmk) and
Granzyme A (Gzma) were also expressed at higher levels, even
though the p values were >0.05 (data not shown). qRT-PCR
analysis showed that Gzmb as well as Gzma and Gzmk were
significantly overexpressed in Tcf7/BMmNK cells (Figure 5A),
while Gzmc was below detection.
Granzymes are stored in lytic granules of NK cells and cyto-
toxic T cells, and their release triggers programmed cell deathindicate the percentage of cells in the respective gate or quadrant. Bar graphs (C
Tcf7+/+ (black), Tcf7/ (open), Tcf7/ p33 Tg (dark gray), and Tcf7/ p45 Tg (
pendent experiments.
Statistical significance was determined by one-way ANOVA but is only shown fo
*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 and ns, not significant (p > 0.05in target cells (Chowdhury and Lieberman, 2008). In addition to
the induction of target cell death, leakage of GzmB from granules
into the cytoplasm can also result in effector cell death (Ida et al.,
2003; Zhang et al., 2006). For example, activated CD4+ T cells,
which lack the intracellular GzmB inhibitor Spi6 (Serpinb9), un-
dergo GzmB-mediated apoptosis (Zhang et al., 2006). We thus
hypothesized that excessive granzyme expression, due to the
absence of Tcf1, induced self-inflicted NK cell death.
To test this hypothesis, we analyzed GzmB protein expression
in BMNK cells by intracellular flow cytometry. Even though wild-
type BM mNK cells constitutively express Gzmb mRNA, GzmB
protein expression is low (Figure 5B) (Fehniger et al., 2007). In
contrast, GzmB was expressed at high levels in Tcf7/ mNK
cells (Figure 5B). This was not simply due to an increased abun-
dance of terminally mature NK cells, which express higher levels
of GzmB, as GzmB was globally increased also in immature
(CD27+CD11b) NK cells (Figure S4C). GzmB was also overex-
pressed in Tcf7/ NK cells developing in mixed BM chimeras
(Figure S4D), indicating that GzmB overexpression was not
solely due to homeostatic effects. On the other hand, the expres-
sion of the GzmB inhibitor Spi6 (Serpinb9) was not different be-
tween Tcf7+/+ and Tcf7/NK cells (Figure 5C). Thus, Spi6 levels
in Tcf7/ NK cells may be too low to neutralize GzmB leaking
into the cytoplasm and prevent NK cell self-destruction.
To further address this possibility, we determined the intracel-
lular localization of GzmB relative to the granule component
Lamp1 (CD107a) using confocal microscopy. Cytokine stimu-
lated wild-type NK cells contained several Lamp1+ granules
per cross section, and GzmB co-localized with these Lamp1+
granules (Figure 5D, top). BM mNK cells from wild-type mice
either lacked Lamp1+ granules (50%) or had very few Lamp1+
granules per cross section. These granules did not contain
GzmB (Figures 5D and 5E, middle). Lamp1 expression was de-
tected in 30% of Tcf7/ BMmNK cells whereby Lamp1 expres-
sion was often diffuse (Figures 5D and 5E, bottom). Interestingly,
a large fraction of Tcf7/ mNK cells expressed GzmB, but not
Lamp1. In such NK cells, GzmB frequently showed a diffuse
cytoplasmic and occasionally nuclear localization (Figures 5D
and 5E). The latter is a feature associated with the execution
phase of GzmB-mediated apoptosis (Trapani et al., 1998). These
data show that Tcf1 deficiency results in excessive expression
andmislocalization of GzmB and suggest that these NK cells un-
dergo GzmB-mediated self-killing.
Excessive Granzyme Expression Impairs NK Cell
Development
We further addressed whether granzyme expression correlated
with impaired NK cell development. In wild-type mice, Gzmb,
Gzma, and Gzmk are not expressed at the pre-NK stage but
are upregulated at the rNK stage (Figure 5F), which coincides
with the acquisition of CD122. In the absence of Tcf1, Gzmb,
Gzma, and Gzmk were super-induced at the rNK stage butand E) depict the mean (±SEM) number of cells in the indicated population in
light gray) mice. Data were compiled from 8 to 25 mice from at least six inde-
r selected comparisons (C and E) or by two-tailed Student’s t test (A), where
). See also Figure S2.
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Figure 4. Tcf1 Ensures NK Cell Survival
(A) BMNK cells were stained with Hoechst to analyze DNA content. Numbers indicate the mean percentage (±SD) of Hoechst+ Tcf7+/+ and Tcf7/NK cells in the
S, G2, or M phase of the cell cycle.
(B) Density plots show gated NK cells that had been incubated for 4 hr (in the absence of growth factor) at 37C and then stained for Annexin V and 7-AAD. Bar
graph depicts the mean percentage (±SD) of Annexin V+ 7-AAD+ NK cells from Tcf7+/+ (black) and Tcf7/ (open) mice.
Data in (A) and (B) are from two or more independent experiments and a total of three to six determinations.
(C) NK cell-enriched splenocytes were labeledwith CFSE and cultured in IL-2. Histograms show the CFSE profile after 5 days of culture, and numbers indicate the
percentage of cells in the corresponding gate.
(D) Bar graph depicts themean fold expansion (±SD) of Tcf7+/+ (black) and Tcf7/ (open) NK cells at day 5 of IL-2 culture relative to input. Data are compiled from
eight independent experiments.
(E) At day 5 of culture in IL-2, NK cells were stained with Annexin V and 7-AAD. Bar graph depicts the mean percentage (±SEM) of Annexin V+ 7-AAD+ NK cells
from Tcf7+/+ (black) and Tcf7/ (open) mice. Data were compiled from two independent experiments.
(F) Purified NK cells from Tcf7+/+ (CD45.1) and Tcf7/mice (CD45.2) were cultured separately or co-cultured at a 1:1 ratio, and NK cell numbers were determined
on day 5 of culture in IL-2. Bar graphs depict the mean fold expansion (±SD) of Tcf7+/+ (black) and Tcf7/ NK cells (open) relative to input. Data are from three
independent experiments.
Statistical significance was determined by two-tailed Student’s t test (B and D–F), where *p < 0.05, **p < 0.01, and ***p < 0.001. See also Figure S4.were not expressed prior to the rNK cell stage (Figure 5F). Thus,
the acquisition of IL-15 responsiveness coincided with the in-
duction of granzyme gene expression, which was limited by
Tcf1. As NK cell development was restored in p45, but not in618 Cell Reports 20, 613–626, July 18, 2017p33, Tg mice (Figures 2B–2E), we next analyzed granzyme
expression in Tcf1 Tg BM NK cells. GzmB protein and
mRNA levels were low in Tcf7+/+ mNK cells, high in Tcf7/
and Tcf7/ p33 mNK cells, and low again in Tcf7/ p45 mNK
cells (Figures 5G, 5H, and S4C). Corresponding expression pat-
ternswere observed forGzma andGzmkmRNA (Figure S4E).We
concluded that the p45 Tg suppressed granzymes and that this
was associated with the restoration of NK cell development.
We next asked whether granzyme deficiency rescued the
developmental defect of Tcf7/ NK cells. To address this, we
crossed Tcf7/ to Gzmb-cluster-deficient mice (Gzmbtm1Ley)
(Heusel et al., 1994), which lack Gzmb and have reduced
Gzmc, Gzmd, and Gzmf expression (Revell et al., 2005). How-
ever, Gzmb cluster deficiency did not restore NK cell develop-
ment in Tcf7/ mice (Figure S5). As Tcf7/ mice lacked pre-
NK cells and granzymes were upregulated only at the rNK stage,
we introduced the p33 Tg, which restores pre-NK cells. How-
ever, BM rNK and mNK cell development was still impaired in
Tcf7/ p33 Tg Gzmb/ mice (Figure S5). Tcf7/ NK cells
also overexpressed Gzma and Gzmk (Figures 5A and 5F), which
are in a separate gene cluster and may redundantly impair NK
cell survival. To test whether granzyme overexpression impaired
NK cell development, we transduced wild-type LinNK1.1 BM
progenitor cells with retroviral constructs coding for granzymes,
followed by in vitro differentiation toward the NK cell lineage with
IL-15 (Williams et al., 1999). Compared to control transduction,
enforced expression of Gzmb greatly reduced the differentiation
of progenitors into NK cells, while there was no effect on B cells
(Figure 5I). Enforced expression of Gzma or Gzmk similarly
reduced NK cell differentiation in vitro (Figure S4F). These effects
were NK cell intrinsic, since non-transduced NK cells present in
the same cultures developed normally (Figure S4F). Thus, exces-
sive expression of granzymes impaired NK cell development.
Increased GzmB Expression Impairs NK Cell-Mediated
Target Cell Killing
We next addressed whether increased granzyme expression
altered the ability of NKcells to kill target cells. To circumvent con-
founding effects due to a difference in NK cell maturation, we
used cells from poly(I:C)-primed mice. We found that the lysis of
MHC-Ilow RMA/S tumor cells by poly(I:C)-primed Tcf7/NK cells
was reduced5- to10-fold compared towild-typeNKcells (Figures
6A and 6B). In addition, Tcf7/NKcells also showed significantly
reduced killing of YAC-1 cells (in part mediated by NKG2D), RMA
cells transfectedwithm157cells (Ly49H), and anti-Thy1 (CD90.2)-
coatedRMAcells (antibody-dependent cell-mediatedcytotoxicity
[ADCC]) (Figure 6B). RMA cells transfected with H60 (NKG2D)
were killed equally efficiently by the two types of NK cells (Fig-
ure 6B). In addition, Tcf7/ mice were severely impaired in their
ability to reject MHC class I (b2 m)-deficient splenocytes in vivo
(Figure 6C) and to prevent the outgrowth of primary B cell acute
lymphoblastic leukemia (B-ALL) cells lacking b2 m (Figure 6D).
The functional impairment was specific for target cell lysis, as
Tcf7/ NK cells efficiently released Lamp1 (CD107) when stimu-
lated with various tumor target cells or with antibodies to specific
activation receptors (Figures S6A and S6D). Moreover, activated
Tcf7/ NK cells had a normal ability to produce chemokines
and cytokines (Figures S6A–S6C). Thus, NK cells from Tcf7/
mice are educated and recognize target cells but have a severely
reduced capacity to kill them.
Based on the increased death of cytokine-activated NK cells
lacking Tcf1 (Figure 4E), we hypothesized that reduced targetcell killing was due to the induction of NK cell death following
activation by target cells. Indeed, Tcf7/, but not Tcf7+/+, NK
cells underwent significant cell death when exposed to suscep-
tible target cells (RMA/S), while resistant target cells (RMA) did
not increase NK cell death (Figures 6E and 6F). To determine
the basis for target-induced NK cell death, we exposed Tcf7/
NK cells to susceptible RMA/S tumor cells in the presence of
selected peptide-based inhibitors. The GzmB inhibitor (z-AAD-
CMK) reduced target-induced apoptosis of Tcf7/ NK cells,
while a negative control peptide (z-FA-CMK) had no effect (Fig-
ures 6E and 6F). GzmB is activated by cathepsin-C-mediated
cleavage of pro-GzmB. A cathepsin C inhibitor (DPPI) also
reduced target-induced apoptosis of Tcf7/ NK cells, while
the control caspase inhibitor z-VAD had no effect (Figure 6F).
Finally, Gzmb cluster deficiency also significantly reduced
target-induced apoptosis of Tcf7/ NK cells (Figure 6G).
Thus, the reduced lytic activity of Tcf7/ NK cells was ac-
counted for by target-induced, GzmB-dependent death of
Tcf7/ NK cells.
Tcf1 Binding to a Regulatory Element Upstream of the
Gzmb Locus Dampens Gzmb Expression
Given the importance of Tcf1-mediated repression of GzmB for
NK cell development and function, we asked if Gzmb was a
Tcf1 target gene. We prepared chromatin from IL-2-expanded
NK cells to determine genome-wide Tcf1 binding using chro-
matin immunoprecipitation (ChIP) followed by deep sequencing
(ChIP-seq). Tcf1 binding was further correlated with histone
3 lysine 4 tri-methylation (H3K4me3) deposition, which is an
epigenetic mark of active chromatin.
We identified 751 Tcf1-binding peaks in Tcf7+/+ relative
to Tcf7/ NK cells. We next addressed whether Tcf1 was
associated with any of the 20 genes that are differentially ex-
pressed in Tcf7+/+ relative to Tcf7/ NK cells (Table S1). Con-
sidering ±50 kb flanking sequence, we noted Tcf1 binding
to the Tcf7 and Gzmb loci. A single Tcf1-binding element
(TBE) was present 26 kb upstream of the Gzmb transcriptional
start site (Figure 7A), which was confirmed by ChIP-qPCR
(Figure 7B). Tcf1 binding to the Gzmb TBE correlated with a
reduction of activating H3K4me3 marks at the Gzmb gene locus
(Figures 7A and 7C) and with reduced Gzmb expression (Fig-
ure 7D). Conversely, Tcf1 binding to the known target Axin2
correlated with an increase of H3K4me3 marks (Figures S7A
and S7C) and increased Axin2 mRNA expression (Figure S7D).
Thus, Tcf1 binding is associated with target gene activation or
suppression.
To further define the function of the Gzmb TBE, we performed
ChIP using antibodies against histone 3 lysine 4 mono-methyl-
ation (H3K4me1) and histone 3 lysine 27 acetylation (H3K27Ac),
which are epigenetic marks associated with enhancer elements.
In wild-type NK cells, the Gzmb TBE was associated with
H3K4me1 and H3K27Ac marks (Figure 7E), indicating that the
TBE is part of a Gzmb enhancer element. Interestingly,
H3K4me1 and H3K27Ac marks at the TBE were significantly
more abundant in Tcf7/ NK cells (Figure 7E). These data
suggested that Tcf1 binding reduced the function of a Gzmb-
associated enhancer element. To further address this possibility,
we cloned a 500-bp fragment, which comprised the Gzmb TBECell Reports 20, 613–626, July 18, 2017 619
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(Figure S7E), upstream of a minimal promoter and a luciferase
reporter gene. We found that this element significantly enhanced
reporter activity upon transient transfection into aGzmB-express-
ing cell line and that co-transfecting Tcf1 cDNA completely
abrogated the increase (Figure 7F). Thus, Tcf1 binding reduced
the activity of a Gzmb-associated enhancer element, which ac-
counted for the reduced Gzmb expression in Tcf1-expressing
NK cells.
DISCUSSION
The transcription factor Tcf1 is essential for the development of
NK cells, but its precise role has not been completely under-
stood. Based on the analysis of Tcf1-deficient and Tcf1-trans-
genic mice, we propose that Tcf1 guides NK cells through three
stages of development andmaturation. Tcf1 expression directed
BM progenitors toward the NK cell lineage and ensured the
survival of NK-committed cells, and its downregulation was
essential for terminal NK cell maturation. In NK-lineage-
committed cells, Tcf1 suppressed GzmB and additional gran-
zyme family members, and this prevented NK cell self-destruc-
tion during development. Tcf1 also protected mature NK cells
from GzmB-dependent self-destruction upon activation with
cytokines or susceptible target cells. Thus, negative regulation
of granzyme expression by Tcf1 played an essential role for
the normal expansion and function of NK-committed cells. Pro-
tection from self-destruction was a stage-specific role of Tcf1,
since pre-NK cells, which also depended on Tcf1, did not ex-
press granzymes.
Unexpectedly, our transcriptome analysis of BM mNK cells
did not identify transcription factors implicated in NK cell devel-
opment as potential Tcf1 targets. This was confirmed using qRT-
PCR analyses, which indicated only minor expression changes
of Nfil3, Id2, and Tbx21 (T-bet) in rNK cells lacking Tcf1. A
more notable reduction was observed for Eomes (2-fold) (dataFigure 5. Tcf1 Deficiency Results in Excessive Granzyme Expression a
(A) qRT-PCR analysis of flow-sorted BM mNK cells from Tcf7+/+ (black) and Tcf7
independent experiments. Error bars are SEM.
(B) Histogramoverlay shows granzymeB (GzmB) expression in gated BMmNKce
(gray fill).
(C) qRT-PCR analysis of BM mNK cells from Tcf7+/+ (black) and Tcf7/ (open) m
ments. Error bars are SEM.
(D and E) Confocal microscopy of cytokine-stimulated NK cells from Tcf7+/+ mice
Tcf7/ mice (bottom two panels) for GzmB (green), Lamp1 (red), and DNA/DAPI
(right) is shown in yellow. (E) Bar graph shows the percentage of BM mNK cells f
express GzmB in the absence of Lamp1. Data are based on the analysis of cros
(F) qRT-PCR analysis of pre-NK and rNK cells from Tcf7+/+ (black) and Tcf7/ (
pendent experiments. Error bars are SEM.
(G) Histogram overlay shows GzmB expression in gated BMmNK cells from Tcf7+
compared to Gzmb/ mice (gray fill).
(H) qRT-PCR analysis of BM mNK cells from Tcf7+/+ (black), Tcf7/ (open), Tcf7
representative of two or three independent experiments. Error bars are SEM.
(I) Lineage-negative (Lin) NK1.1wild-type BMprogenitors were transducedwith
by hCD2. Progenitors were then differentiated toward the NK cell lineage for 3–5
efficiency (hCD2+) (left), GzmB expression by gated hCD2+ cells (middle), and NK
mean percentages (±SD) of transduced cells (hCD2+) and of transduced cells e
independent experiments with a total of three to six determinations.
Statistical significance was determined by one-way ANOVA and is only shown for
*p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 and ns, not significant p > 0not shown). However, Eomes deficiency does not grossly alter
the size of the BM NK cell compartment (Gordon et al., 2012).
On the other hand, granzyme expression can be detrimental,
and cells need to protect themselves from the cell-intrinsic ac-
tion of granzymes. Deletion of the intracellular GzmB inhibitor
Spi-6 disrupted the integrity of lytic granules and resulted in
accelerated GzmB-mediated death of activated CD4+ T cells
(Zhang et al., 2006). The observations suggested that GzmB
leaks into the cytoplasm and that a cytoplasmic excess of
GzmB relative to Spi6 results in self-destruction. Absence of
Tcf1 in NK cells did not impact Spi6 expression, indicating that
excessive GzmB expression overcame the protective effect of
Spi6. Self-destruction via GzmB leakage is not restricted to
mutant NK cells, as this was also shown when wild-type NK cells
were activated with monoclonal antibodies (mAbs) to certain
activation receptors (Ida et al., 2003). Interestingly, GzmB-medi-
ated self-destruction is not restricted to cytotoxic effector cells,
as it is also observed in hematopoietic stem cells (HSCs) lacking
c-myc andN-myc or when wild-type HSCs are exposed to an in-
flammatory environment or chemotherapy (Carnevalli et al.,
2014). It will thus be of interest to determine whether different
cell types use similar mechanisms to limit GzmB expression.
Our mechanistic analyses suggested that Tcf1 binding
reduced the activity of a Gzmb-associated regulatory element,
and that could account for the reduced Gzmb expression in
Tcf1-expressing NK cells. Based on the original targeting of
the Gzmb gene (Pham et al., 1996; Revell et al., 2005), it
was proposed that the expression of Gzmb and linked genes
is coordinated by a locus control region (LCR) region. As we
identified a single TBE associated with the Gzmb cluster, yet
several Gzm genes were increased in the absence of Tcf1, it is
tempting to speculate that the regulatory element identified
herein represents the putative LCR. However, further work will
be needed to verify this hypothesis. On the other hand, Gzma
and Gzmk, which reside in a separate gene cluster, were alsond Mislocalization
/ (open) mice for Gzmb, Gzma, and Gzmk. Data are representative of three
lls from Tcf7+/+ (black) and Tcf7/mice (red) as compared toGzmb/ controls
ice for Serpin9b (Spi6). Data are representative of three independent experi-
(top two panels) or BMmNK cells from Tcf7+/+ mice (middle two panels) or from
(blue). Colocalization of GzmB (green) and Lamp1 (red) in the merged images
rom Tcf7+/+ (black) and Tcf7/ (open) mice that are GzmB+ or Lamp1+ or that
s sections from 70 cells per genotype.
open) mice for Gzmb, Gzma, and Gzmk. Data are representative of two inde-
/+ (black), Tcf7/ (red), Tcf7/ p33 Tg (green), and Tcf7/ p45 Tg mice (blue)
/ p33 Tg (dark gray), and Tcf7/ p45 Tg (light gray) mice for Gzmb. Data are
a control retrovirus (expressing hCD2) or a retrovirus coding for GzmB followed
days using IL-15. Representative flow cytometry plots show the transduction
p46 versus CD19 expression among hCD2+ cells (right). Bar graphs depict the
xpressing NKp46 (NK cells) or CD19 (B cells). Data were compiled from two
selected comparisons (H) or by two-tailed Student’s t test (A, C, F, and I), where
.05. See also Figures S4 and S5.
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overexpressed in the absence of Tcf1, but we did not detect Tcf1
binding in the vicinity of the Gzma cluster. However, there is
evidence for Tcf1 binding 50 kb downstream of the Gzma
cluster in CD8+ thymocytes (Xing et al., 2016). In these cells,
Tcf1 is also associated with Gzmb-associated regulatory
element described herein. Thus, all granzymes may be subject
to direct negative regulation by Tcf1.
Consistent with a negative regulatory role, Tcf1 can associate
with Groucho/TLE co-repressors (Roose et al., 1998), exert his-
tone deacetylase activity (Xing et al., 2016), or silence genes in
cooperation with Runx3 (Steinke et al., 2014). These negative
regulatory roles can bemediated by p33 and p45 Tcf1. However,
p45, but not p33, suppressed Gzmb in NK cells. Tcf1 p45 can
associate with b-catenin and/or g-catenin, which usually pro-
motes the expression of target genes, such as Axin2. However,
there are few examples of target genes that are repressed by Tcf/
b-catenin signaling, such as E-cadherin expression in the skin
(Jamora et al., 2003). However, transcriptional repression by
Tcf/b-catenin is poorly understood compared to transcriptional
activation. Thus, the precise mechanism of Tcf1-mediated
GzmB suppression will require further investigation. Irrespec-
tively, we show that Tcf1 limits granzyme expression and that
this is important to prevent NK cell self-destruction. Limiting
the expression of granzymes thus represents an unexpected
requirement for the proper development and function of NK cells.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6 (B6) mice were purchased from Harlan OLAC. CD45.1 congenic B6
mice were bred in-house. Tcf7/ (Verbeek et al., 1995), Tcf1 p33, and Tcf1
p45 transgenic (Ioannidis et al., 2001) and Tcf7-GFP reporter (Utzschneider
et al., 2016), Gzmbtm1Ley Gzmb-cluster-deficient mice (termed Gzmb/
herein) (Heusel et al., 1994) have been described previously. Tcf7/ Tcf7-
GFP, Tcf7/ p33 Tg, Tcf7/ p45 Tg, Tcf7/ Gzmb/, and Tcf7/ p33 Tg
Gzmb/ mice were obtained by breeding. Animal experiments were
performed in 6- to 12-week-old male or female mice in compliance with theFigure 6. GzmB Mediates Target Cell-Induced NK Cell Death
(A) Splenocytes from poly(I:C) primed Tcf7+/+ (black circles) or Tcf7/ (open circ
RMA/S (MHC-Ilow) tumor cells at the indicated effector to target cell ratios. After 4–
graph shows the mean percentage (±SD) of specific lysis of triplicate determinat
least six independent experiments.
(B) Splenocytes from poly(I:C)-primed Tcf7+/+ or Tcf7/ mice containing equal
effector/target ratio. Bar graph depicts the mean percentage (±SD) of specific tum
independent experiments.
(C) B6 (H-2b) and b2 m/ splenocytes were labeled with a high and low dose of
primed with poly(I:C). The abundance of CFSE-labeled cells in the spleen was dete
b2 m/ relative to H-2b splenocytes by Tcf7+/+ or Tcf7+/ (black) or Tcf7/ (op
pendent experiments.
(D) BCR-ABL+ (GFP+) primary B cell acute leukemia (B-ALL) cell lines lacking b2
Injection of anti-NK1.1 mAb into Tcf7+/+ (open circles) or Tcf7/ (open squares) m
B-ALL cells (GFP+) in peripheral blood on day 10 after injection, and the graph
experiment using poly(I:C)-primed mice.
(E and F) Splenocytes from poly(I:C)-treated Tcf7+/+ and Tcf7/mice were expos
without tumor cells, in the absence of () or in the presence of a GzmB inhibit
(z-VAD), or a cathepsin C inhibitor (DPPI). (E) Representative analysis of 7-AAD up
depicts the mean percentage (±SEM) of 7-AAD+ NK cells from Tcf7 +/+ (black) an
(G) Splenocytes from poly(I:C)-treated Tcf7+/+ Gzmb+/+, Tcf7+/+ Gzmb/, Tcf7/
cells. Bar graph depicts the mean percentage (±SEM) of 7AAD+ NK cells (CD3C
Statistical significance was determined by one-way ANOVA and is only shown for
(B, C, and F), where *p < 0.05, **p < 0.01, ***p < 0.001, and ns, not significant pUniversity of Lausanne Institutional regulations and were approved by the
veterinary authorities of the Canton de Vaud.Flow Cytometry
Spleen and BM cells were treated with ACK buffer (0.15 M NH4Cl, 1 mM
KHCO3, and 0.1 mM EDTA [pH 7.3]) to remove erythrocytes. Subsequently,
cells were incubated with ZombieAqua (BioLegend) to exclude dead cells
and anti-CD16/32 (2.4G2) hybridoma supernatant to block Fc receptors before
staining with fluorescent mAbs (Table S2) for subsequent analyses or cell
sorting using flow cytometry.
BM progenitor populations were identified by excluding cells stained for
a cocktail of Alexa-Fluor-700-conjugated anti-CD3ε, CD4, CD8, CD11b,
CD19, NK1.1, Ter119, and GR-1 mAbs. The resulting lineage-negative
(Lin) cells were further labeled to identify CLP (Lin2B4+CD27+CD127+
CD135+CD122), EILP (LinCD127Thy1Tcf7-GFP+), pre-NK (Lin
2B4+CD27+CD127+CD135CD122), rNK (Lin2B4+CD27+CD127+CD135
CD122+), and mNK cells (CD3CD122+DX5+NK1.1+). The maturation status
of BM mNK and spleen NK cells was assessed using CD11b, CD27, and
KLRG1 staining.
Intracellular staining for Tcf1 and GzmB was performed using the Foxp3
transcription factor staining buffer set (eBioscience) according to the manu-
facturer’s protocol.
NK cell proliferation was assessed using Hoechst staining for ex vivo
analyses or carboxyfluorescein succinimidyl ester (CFSE) dilution for NK cells
cultured in vitro using recombinant human IL-2 (500 ng/mL) or IL-15. NK cell
death was determined using 7-aminoactinomycin D (7-AAD) uptake with or
without Annexin V staining.
Data were acquired on an LSRII or FACSCanto flow cytometer (Becton
Dickinson) and analyzed with FlowJo (Tree Star). Alternatively, cells were
subjected to sorting on a FACSAria (Becton Dickinson).NK Cell Function and Target-Induced NK Cell Death
Mice were primed with 200 mg poly(I:C) (Labforce) intraperitoneally (i.p.), and
spleens were harvested 24 hr later. Spleen cells were exposed to CFSE-
labeled NK cell-resistant RMA (H-2b) or susceptible RMA/S (MHC-Ilow) cells.
4 hr later, 7-AAD was added, and the percentage of 7-AAD+ (dead) tumor cells
among CFSE+ target cells was determined by flow cytometry. Alternatively,
7-AAD uptake by gated NK cells (CD3CD19-NK1.1+) was used to assess
target induced NK cell death in the absence or presence of the GzmB inhibitor
(100 mM z-AAD-CMK), its negative control (100 mM z-FA-CMK) (Enzo), theles) mice containing equal numbers of NK cells were added to CFSE-labeled
5 hr, 7-AAD uptake by tumor cells was used to determine target cell killing. The
ions at the indicated effector to target cell ratios. Data are representative of at
numbers of NK cells were added to the indicated tumor target cells at a 10:1
or cell lysis (7-AAD+) by Tcf7+/+ (black) or Tcf7/ (open) splenocytes from six
CFSE, respectively, before injection into Tcf7+/+ or Tcf7/mice that had been
rmined 24 hr later. Bar graph depicts the mean percentage (±SEM) rejection of
en) mice. Data were compiled from three to five recipient mice from two inde-
m were injected into Tcf7+/+ (black circles) or Tcf7/ (black squares) mice.
ice was used to deplete NK cells (DNK1.1). Histograms depict the presence of
depicts survival of mice over time. Similar data were obtained in a second
ed to NK cell-resistant RMA or NK cell-sensitive RMA/S tumor cells or cultured
or (z-AAD-CMK), a negative control inhibitor (z-FA-CMK), a caspase inhibitor
take by gated NK cells (CD3CD19NK1.1+) after a 4 hr culture. (F) Bar graph
d Tcf7/ (open) mice. Data are from three to nine determinations.
Gzmb+/+, and Tcf7/ Gzmb/mice were exposed to RMA or RMA/S tumor
D19NK1.1+) 4 hr later. Data are from 3 to 11 determinations.
selected comparisons (G) or by Student’s t test for the indicated comparisons
> 0.05. See also Figure S6.
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Figure 7. Tcf1 Binds to a Regulatory Element Upstream of the GzmB Locus
(A) Integrative genome viewer screenshots showing the ChIP-seq binding profiles of Tcf1, H3K4me3, and input (background) at theGzmB locus (+26 kb) in IL-2-
activated NK cells isolated from Tcf7+/+ (black tracks) and Tcf7/ (red tracks) mice.
(B and C) IL-2-expanded NK cells from Tcf7+/+ (black) and Tcf7/ (open) mice were used for (B) Tcf1 or (C) H3K4me3 ChIP. qPCR was performed using primers
surrounding the GzmB Tcf1-binding element (Gzmb TBE) (B) or the Gzmb gene (C). Results are expressed as fold change relative to control immunoglobulin G
(IgG) ChIP. Data are representative of two or three experiments. Error bars are SEM.
(D) qRT-PCR analysis of Gzmb expression by IL-2-activated NK cells from Tcf7+/+ (black) and Tcf7/ (open) mice. Data are representative of two experiments.
Error bars are SEM.
(E) IL-2-expandedNK cells from Tcf7+/+ (black) and Tcf7/ (open) mice were used for H3K4me1 andH3K27Ac ChIP followed by qPCR for theGzmb TBE. Results
are expressed as fold change relative to control IgG ChIP. Data are representative of two or three experiments. Error bars are SEM.
(F) Bar graph depicts reporter gene activity in transiently transfected CTLL-2 cells. Cells were transfected either with an empty pGL3 firefly luciferase vector (open)
or a pGL3 vector containing a 500-bp fragment surrounding the Gzmb TBE (black), either without or with full-length Tcf1 (dark gray and light gray, respectively).
Results were normalized to renilla luciferase transfection controls and subsequently to the results obtained with pGL3 alone. Data are compiled from three
independent experiments. Error bars are SEM.
Statistical significance was determined by one-way ANOVA and is only shown for selected comparisons (F) or by two-tailed Student’s t test (B–E), where *p <
0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001. See also Figure S7.caspase inhibitor (50 mM z-VAD), or the cathepsin C inhibitor (15–25 mM DPPI)
(MP Biomedicals).
Gene Expression and ChIP-Seq Analyses
Total cellular RNA from fluorescence-activated cell sorting (FACS)-purified
Tcf7+/+ and Tcf7/BMmNK cells was used for Affymetrix gene array analyses
(GTF facility, University of Lausanne). Probe sets with adjusted p values (false
discovery rate) <0.05 were used to identify differentially expressed genes.
For qPCR, cDNA was synthesized with oligo-dT or random hexamers, and
PCR reactions were performed using the primers listed in Table S3 and a Light-624 Cell Reports 20, 613–626, July 18, 2017Cycler FastStart DNA Master SYBR green I kit (Roche). Quantifications were
done relative to Hprt using the LightCycler relative quantification software
1.0 (Roche).
For ChIP-seq, splenic NK cells were expanded in IL-2 for 5 days. 43 107 NK
cells were cross-linked with 1% formaldehyde. Following lysis, chromatin was
sheared to 0.3–1 kb before immunoprecipitation with antibodies specific for
Tcf1, H3K4me3, H3K4me1, H3K27Ac, or a rabbit control antibody (Table S2)
and protein-G agarose beads (Roche). Purified DNA was either used for
qPCR with the primers indicated in Table S3 or sequenced. For sequencing,
libraries were prepared using the NEBNext Chip-Seq Library Prep Master
Mix Set (NEB) and sequenced on a Illumina Hiseq 2500 (GTF facility, University
of Lausanne). Reads were mapped to reference genome mm10/GRCm38
using Bowtie (version 2.1.0) and Peak calling was performed using MACS
(version 1.4). Samples were compared using the UCSC genome browser or
the Integrative Genome Browser.
Statistical Analysis
Statistical significance was determined using an unpaired two-tailed Student’s
t test for unequal variances or using a one-way ANOVA along with the
Dunnett’s post-test to adjust for multiple comparisons (using a 95% confi-
dence interval). In all cases, p values are indicated as *p < 0.05, **p < 0.01,
***p < 0.001, ****p < 0.0001, and not significant (ns, p > 0.05).
Additional and more detailed experimental information is available in
Supplemental Experimental Procedures.
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